In this paper, developed during the COVID-19 pandemic to assist sponsors with trial continuity, Signant Clinical Vice Presidents Lew Fredane and David Daniel offer strategies to effectively transition from site-based to at-home assessments while maintaining measurement accuracy.
Highly applicable in today's landscape of global, multi-site clinical trials, our experts provide a detailed sample rater training and calibration curriculum to ensure reliable ClinRO data from remotely administered assessments.
